Zydus Lifesciences has announced plans to develop the TCV Shigella combination vaccine in collaboration with its research partner and the Gates Foundation for children aged under 5 years. This is expected to be the world’s first combination vaccine providing dual protection against such deadly enteric diseases that take over 4,00,000 lives globally. Why Is This …